Last reviewed · How we verify

NCT04050839

Pain Neuroscience Education in Patients with Fibromyalgia

Completed NA Last updated 15 October 2024
What this trial tests

NA trial testing Pain neuroscience education in Pain, Chronic in 40 participants. Completed in 15 July 2021.

Timeline
15 September 2019
Primary endpoint
15 June 2021
15 July 2021

Quick facts

Lead sponsorKutahya Health Sciences University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingsingle
Primary purposetreatment
Enrollment40
Start date15 September 2019
Primary completion15 June 2021
Estimated completion15 July 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kutahya Health Sciences University

Who can join

Adults 18 to 65, any sex, with Pain, Chronic or Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many patients with fibromyalgia have little understanding of their condition, leading to maladaptive pain cognitions and coping strategies. Current research has suggested the use of physiotherapy and rehabilitation in addition to cognitive patient education in the treatment of fibromyalgia syndrome. This study aimed to explore the effectiveness of pain neuroscience education in patients with fibromyalgia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Pain neuroscience education

Trials testing the same drug.

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

Other Kutahya Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04050839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing